What's new at Łukasiewicz – PORT?
- Reading time: 3 min.
As the head of the Translational Neuropsychiatry Research Group at Łukasiewicz – PORT, Dr. Ali Jawaid studies transgenerational trauma and explores how neuroscience can support conflict prevention and mediation.
- Reading time: 3 min.
Glioma has long been a key area of Dr. hab. Grzegorz Chodaczek’s research. His new project, conducted with the 4th Military Clinical Hospital in Wrocław, will center on advancing brain tumor diagnostics.
- Reading time: 3 min.
The National Science Centre has awarded funding to two projects: research by Dr. hab. Marek Wagner on innate lymphoid cells in melanoma development and work involving Prof. Andrzej Białowiec on a new tool for assessing biochar safety.
- Reading time: 3 min.
With nearly PLN 2 million in new funding, Łukasiewicz – PORT will advance work on a photonic biosensor designed to support fast, sensitive diagnostics closer to the patient.
- Reading time: 3 min.
With funding from the Ministry of Science and Higher Education, Dr. Paweł Sega is building the BioValid platform, which will enable the analysis of microorganisms at the single-cell level.
- Reading time: 3 min.
Dr. Krzysztof Czyż represented Łukasiewicz – PORT at the Photonics Partnership Annual Meeting in Brussels, a key European event on the future of photonics, with discussions covering technologies developed at the institute and solutions for modern diagnostics.
- Reading time: 3 min.
How does the nervous system integrate signals from the body and the outside world? In the next open seminar, Dr. Kuo-Sheng Lee will discuss how animals monitor both their environment and internal states.
- Reading time: 3 min.
The Biobank Research Group has increased its biological sample collection by 500%, enabling the Population Diagnostics Center, led by Dr. hab. Patrycja Gazińska, to reach a key milestone in the P4Health project funded under Teaming for Excellence.
- Reading time: 3 min.
From May 18 to 21, 2027, Wrocław will host the 12th International γδ T Cell Conference, a leading global meeting for researchers studying γδ T cells – immune cells with tremendous therapeutic potential.
- Reading time: 3 min.
The Virtual Research Institute (WIB), operating within the structure of Łukasiewicz – PORT, is seeking partners for the commercialization of an innovative mRNA-based technology. The technology was developed by one of WIB’s research teams, and we are looking for a partner to help further develop and bring it to market.
